🚀 VC round data is live in beta, check it out!
Lonza Group Valuation Multiples
Discover revenue and EBITDA valuation multiples for Lonza Group and similar public comparables like CSL, Bayer, Samsung BioLogics, Zoetis and more.
Lonza Group Overview
About Lonza Group
Lonza Group is a contract development and manufacturing organization. It operates under four segments: small molecules, biologics, cell and gene, and capsules and health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides development and manufacturing services throughout the entire lifecycle of a product, from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.
Founded
1897
HQ
Employees
18.5K
Website
Financials (LTM)
EV
$53B
Lonza Group Financials
Lonza Group reported last 12-month revenue of $9B and EBITDA of $3B.
In the same LTM period, Lonza Group generated $3B in gross profit, $3B in EBITDA, and $1B in net income.
Revenue (LTM)
Lonza Group P&L
In the most recent fiscal year, Lonza Group reported revenue of $8B and EBITDA of $3B.
Lonza Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $9B | XXX | $8B | XXX | XXX | XXX |
| Gross Profit | $3B | XXX | $3B | XXX | XXX | XXX |
| Gross Margin | 36% | XXX | 35% | XXX | XXX | XXX |
| EBITDA | $3B | XXX | $3B | XXX | XXX | XXX |
| EBITDA Margin | 32% | XXX | 32% | XXX | XXX | XXX |
| EBIT Margin | 22% | XXX | 21% | XXX | XXX | XXX |
| Net Profit | $1B | XXX | $1B | XXX | XXX | XXX |
| Net Margin | 15% | XXX | 14% | XXX | XXX | XXX |
| Net Debt | — | — | $4B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Lonza Group Stock Performance
Lonza Group has current market cap of $48B, and enterprise value of $53B.
Market Cap Evolution
Lonza Group's stock price is $693.82.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $53B | $48B | 2.0% | XXX | XXX | XXX | $16.92 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialLonza Group Valuation Multiples
Lonza Group trades at 6.1x EV/Revenue multiple, and 19.3x EV/EBITDA.
EV / Revenue (LTM)
Lonza Group Financial Valuation Multiples
As of April 18, 2026, Lonza Group has market cap of $48B and EV of $53B.
Equity research analysts estimate Lonza Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Lonza Group has a P/E ratio of 37.8x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $48B | XXX | $48B | XXX | XXX | XXX |
| EV (current) | $53B | XXX | $53B | XXX | XXX | XXX |
| EV/Revenue | 6.1x | XXX | 6.3x | XXX | XXX | XXX |
| EV/EBITDA | 19.3x | XXX | 19.8x | XXX | XXX | XXX |
| EV/EBIT | 28.3x | XXX | 29.6x | XXX | XXX | XXX |
| EV/Gross Profit | 17.1x | XXX | 18.1x | XXX | XXX | XXX |
| P/E | 37.8x | XXX | 41.0x | XXX | XXX | XXX |
| EV/FCF | 237.8x | XXX | 887.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Lonza Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Lonza Group Margins & Growth Rates
Lonza Group's revenue in the last 12 month grew by 9%.
Lonza Group's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.1M for the same period.
Lonza Group's rule of 40 is 42% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Lonza Group's rule of X is 57% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Lonza Group Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 9% | XXX | 8% | XXX | XXX | XXX |
| EBITDA Margin | 32% | XXX | 32% | XXX | XXX | XXX |
| EBITDA Growth | 11% | XXX | 10% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 42% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 57% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.5M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 8% | XXX | 8% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 10% | XXX | 10% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 1% | XXX | 2% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 14% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Lonza Group Public Comps
See public comps and valuation multiples for other Contract Research & Manufacturing and Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Lonza Group | XXX | XXX | XXX | XXX | XXX | XXX |
| CSL | XXX | XXX | XXX | XXX | XXX | XXX |
| Bayer | XXX | XXX | XXX | XXX | XXX | XXX |
| Samsung BioLogics | XXX | XXX | XXX | XXX | XXX | XXX |
| Zoetis | XXX | XXX | XXX | XXX | XXX | XXX |
| argenx | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Lonza Group M&A Activity
Lonza Group acquired XXX companies to date.
Last acquisition by Lonza Group was on XXXXXXXX, XXXXX. Lonza Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Lonza Group
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialLonza Group Investment Activity
Lonza Group invested in XXX companies to date.
Lonza Group made its latest investment on XXXXXXXX, XXXXX. Lonza Group invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Lonza Group
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Lonza Group
| When was Lonza Group founded? | Lonza Group was founded in 1897. |
| Where is Lonza Group headquartered? | Lonza Group is headquartered in Switzerland. |
| How many employees does Lonza Group have? | As of today, Lonza Group has over 18K employees. |
| Is Lonza Group publicly listed? | Yes, Lonza Group is a public company listed on SIX Swiss Exchange. |
| What is the stock symbol of Lonza Group? | Lonza Group trades under LONN ticker. |
| When did Lonza Group go public? | Lonza Group went public in 2002. |
| Who are competitors of Lonza Group? | Lonza Group main competitors are CSL, Bayer, Samsung BioLogics, Zoetis. |
| What is the current market cap of Lonza Group? | Lonza Group's current market cap is $48B. |
| What is the current revenue of Lonza Group? | Lonza Group's last 12 months revenue is $9B. |
| What is the current revenue growth of Lonza Group? | Lonza Group revenue growth (NTM/LTM) is 9%. |
| What is the current EV/Revenue multiple of Lonza Group? | Current revenue multiple of Lonza Group is 6.1x. |
| Is Lonza Group profitable? | Yes, Lonza Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Lonza Group? | Lonza Group's last 12 months EBITDA is $3B. |
| What is Lonza Group's EBITDA margin? | Lonza Group's last 12 months EBITDA margin is 32%. |
| What is the current EV/EBITDA multiple of Lonza Group? | Current EBITDA multiple of Lonza Group is 19.3x. |
| What is the current FCF of Lonza Group? | Lonza Group's last 12 months FCF is $224M. |
| What is Lonza Group's FCF margin? | Lonza Group's last 12 months FCF margin is 3%. |
| What is the current EV/FCF multiple of Lonza Group? | Current FCF multiple of Lonza Group is 237.8x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.